16
Feb
NIAID continues to encourage qualified investigators with expertise in infectious and immune-mediated diseases, including primary immunodeficiency diseases (PID) to submit applications in response to NIH-wide announcements to help elucidate the molecular basis of these disorders and to advance precision therapies.…